Abstract
BackgroundGanciclovir (Cymevene) has traditionally been the drug of choice for the treatment of cytomegalovirus infections; it should be administered intravenously because it has low bioavailability. The development of the highly...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have